Atherectomy Devices Market 2021 Analysis & Forecast To 2030 By Key Players, Share, Trend, Segmentation

 

Global Atherectomy Devices Market Overview
The global atherectomy devices market is projected to expand at a compound annual growth rate of approximately 8% during the forecast period, supported by the increasing burden of cardiovascular and peripheral vascular diseases worldwide. The rising prevalence of peripheral artery disease and coronary artery disease, combined with the rapid growth of the aging population, has significantly increased the demand for advanced vascular intervention solutions.

Get Free Sample Report: https://meditechinsights.com/atherectomy-devices-market/request-sample/

Additionally, the growing incidence of lifestyle-related conditions such as diabetes and obesity has further elevated the risk of arterial blockages, thereby accelerating the need for effective plaque-removal technologies. The shift toward minimally invasive procedures and the expanding network of outpatient and ambulatory surgical centers are also contributing to the steady growth of the atherectomy devices market. However, the high cost associated with advanced atherectomy devices and related procedures remains a key barrier, particularly in price-sensitive healthcare systems and developing regions.

Atherectomy Devices Market Scope and Clinical Significance
The atherectomy devices market focuses on the development and commercialization of specialized medical devices designed to remove atherosclerotic plaque from narrowed or blocked blood vessels. These devices play a critical role in the management of peripheral artery disease and coronary artery disease by restoring adequate blood flow through minimally invasive, catheter-based techniques. Atherectomy offers an effective alternative to traditional surgical procedures such as bypass surgery, enabling targeted plaque removal with reduced procedural risk.
Atherectomy systems are commonly used in image-guided vascular interventions and are designed to preserve vessel integrity while minimizing trauma to surrounding tissues. The market encompasses various device categories, including directional atherectomy systems that excise plaque in a controlled manner, rotational atherectomy devices that grind calcified deposits, orbital atherectomy systems that sand plaque circumferentially, and laser atherectomy devices that vaporize plaque using high-energy light. Supporting accessories and single-use disposables also form an integral part of the market, ensuring procedural safety and effectiveness.
Accurate diagnosis and pre-procedural planning are essential components of atherectomy-based treatments. Diagnostic modalities such as Doppler ultrasound, angiography, magnetic resonance angiography, and computed tomography angiography are widely utilized to assess arterial narrowing and determine plaque composition and location. These imaging techniques support clinicians in selecting the most appropriate atherectomy approach and optimizing treatment outcomes.

Growing Preference for Minimally Invasive Vascular Interventions
The rising demand for minimally invasive treatments has emerged as one of the most significant drivers of the atherectomy devices market. Patients and healthcare providers increasingly favor minimally invasive vascular procedures due to their numerous advantages over conventional open surgeries. These benefits include shorter hospital stays, reduced recovery times, lower risk of post-operative complications, and improved overall patient satisfaction. As healthcare systems aim to reduce procedural costs and hospital resource utilization, minimally invasive solutions such as atherectomy are gaining widespread acceptance.
Atherectomy has become a preferred treatment modality for peripheral artery disease, particularly in complex and calcified lesions where balloon angioplasty alone may be insufficient. By directly removing plaque rather than simply compressing it against the vessel wall, atherectomy improves luminal gain and enhances blood flow restoration. This approach helps preserve the natural structure of the artery, reduces vessel recoil, and lowers the risk of restenosis. In many cases, atherectomy can minimize or eliminate the need for permanent implants such as stents, reducing long-term complications and improving vessel flexibility.
Regulatory approvals for innovative atherectomy technologies and growing clinical evidence supporting their safety and efficacy are further accelerating adoption. As a result, atherectomy devices are increasingly being incorporated into standard treatment protocols for vascular diseases across hospitals and specialized vascular centers worldwide.

Impact of AI, Robotics, and Combination Therapies on Market Growth
Technological advancements involving artificial intelligence, robotics, and combination therapies are reshaping the landscape of vascular interventions and driving the evolution of the atherectomy devices market. AI-powered imaging and navigation systems are being integrated into atherectomy procedures to provide real-time lesion analysis, enhanced visualization, and precise guidance during interventions. These capabilities allow clinicians to make data-driven decisions, optimize device positioning, and improve procedural accuracy, ultimately enhancing patient safety and outcomes.
Robotic-assisted atherectomy systems represent another significant advancement, offering improved catheter control, consistent precision, and reduced dependence on manual manipulation. Robotics help mitigate physician fatigue during lengthy and complex procedures, while also reducing radiation exposure and improving ergonomic efficiency. As robotic platforms become more sophisticated and accessible, their adoption in vascular interventions is expected to increase steadily.
Combination therapy approaches are also gaining traction, particularly the use of atherectomy followed by drug-coated balloon angioplasty. This sequential treatment strategy allows for more effective drug delivery into the vessel wall after plaque removal, enhancing therapeutic efficacy and reducing neointimal hyperplasia. Clinical studies have demonstrated that combination therapies can significantly lower restenosis rates compared to traditional balloon angioplasty alone, supporting their growing adoption in complex peripheral artery disease cases.

Competitive Landscape and Strategic Developments
The global atherectomy devices market is characterized by intense competition among established multinational corporations and innovative emerging players. Market participants are actively pursuing strategies such as product innovation, technology upgrades, strategic partnerships, mergers and acquisitions, and geographic expansion to strengthen their market position. Companies are investing heavily in research and development to introduce next-generation atherectomy systems with improved safety, precision, and ease of use.
Collaborations with hospitals, research institutions, and technology providers are enabling manufacturers to accelerate product development and clinical validation. In addition, expanding distribution networks and increasing presence in emerging markets are key priorities for companies seeking to capitalize on the growing demand for advanced vascular intervention solutions.

Key Market Drivers
Growing preference for minimally invasive vascular procedures among patients and clinicians
Rising prevalence of peripheral artery disease and coronary artery disease globally
Increasing incidence of diabetes and obesity contributing to vascular complications
Continuous technological advancements in atherectomy systems and imaging tools
Rapid growth of the geriatric population, which is more susceptible to vascular disorders

Attractive Growth Opportunities
Integration of artificial intelligence and robotic technologies into vascular surgery workflows
Rising demand for atherectomy procedures in outpatient and ambulatory surgical centers
Expansion of atherectomy device adoption across emerging and developing healthcare markets

Key Players in the Global Atherectomy Devices Market
• Becton, Dickinson and Company
• Medtronic plc
• Koninklijke Philips N.V.
• Boston Scientific Corporation
• Abbott Laboratories Inc.
• Avinger, Inc.
• AngioDynamics, Inc.
• BIOTRONIK
• Rex Medical, L.P.
• OrbusNeich Medical Group Holdings Limited

Key Request a free sample copy or view report summary:

https://meditechinsights.com/atherectomy-devices-market/request-sample/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.